Caroline Vilhav

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer.

ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer.

Journal: Annals of surgical oncology

Published: August 19, 2026

ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer.

ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer.

Journal: Annals of surgical oncology

Published: July 15, 2026

Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer.

Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer.

Journal: Annals of surgical oncology

Published: March 03, 2026

Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine.

Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine.

Journal: Oncology letters

Published: September 16, 2024

Adjunct mucin biomarkers MUC2+MUC5AC and MUC5AC+PSCA in a clinical setting identify and may improve correct selection of high-risk pancreatic lesions for surgery.

Adjunct mucin biomarkers MUC2+MUC5AC and MUC5AC+PSCA in a clinical setting identify and may improve correct selection of high-risk pancreatic lesions for surgery.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: May 08, 2024

Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer.

Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer.

Journal: Cancer research communications

Published: January 12, 2024

Minimally invasive robot-assisted and laparoscopic distal pancreatectomy in a pan-European registry a retrospective cohort study.

Minimally invasive robot-assisted and laparoscopic distal pancreatectomy in a pan-European registry a retrospective cohort study.

Journal: International journal of surgery (London, England)

Published: December 11, 2023

Genetics and Therapeutic Responses to Tumor-Infiltrating Lymphocyte Therapy of Pancreatic Cancer Patient-Derived Xenograft Models.

Genetics and Therapeutic Responses to Tumor-Infiltrating Lymphocyte Therapy of Pancreatic Cancer Patient-Derived Xenograft Models.

Journal: Gastro hep advances

Published: August 09, 2021

C-reactive protein identifies patients at risk of postpancreatectomy hemorrhage.

C-reactive protein identifies patients at risk of postpancreatectomy hemorrhage.

Journal: Langenbeck's archives of surgery

Published: February 25, 2021

Resectable, borderline, and locally advanced pancreatic cancer-"the good, the bad, and the ugly" candidates for surgery?

Resectable, borderline, and locally advanced pancreatic cancer-"the good, the bad, and the ugly" candidates for surgery?

Journal: Journal of gastrointestinal oncology

Published: September 17, 2020

Fractional uptake of circulating tumor cells into liver-lung compartments during curative resection of periampullary cancer.

Fractional uptake of circulating tumor cells into liver-lung compartments during curative resection of periampullary cancer.

Journal: Oncology letters

Published: April 23, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026